Literature DB >> 18298952

Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.

Vânia F Cordeiro1, Diana C S N Pinheiro, Geraldo B Silva, José Wellington O Lima, Rosa M S Mota, Alexandre B Libório, Elizabeth F Daher.   

Abstract

BACKGROUND: To compare estimated glomerular filtration rate (GFR) by Schwartz formula and cystatin C-derived formula in a large population of children with a large spectrum of renal disease.
METHODS: Serum creatinine, cystatin C and estimated GFR were determined in 273 children, 254 with renal disease, and a mean age of 10.0+/-4.4 y. Nineteen children were used as control, with a mean age of 8.5+/-4.2 y.
RESULTS: The children had nephrotic syndrome (16.5%), glomerulonephritis (11.4%), neurogenic bladder (11.4%), hydronephrosis (9.8%), asymptomatic hematuria (11%), chronic renal disease (5.9%) and other diseases (11%). Cystatin C, creatinine, Schwartz estimated GFR and cystatin C estimated GFR (mean+/-SD) were 1.30+/-1.03 mg/dl, 0.82+/-1.20 mg/l, 143+/-72 ml/min/1.73 m(2) and 88+/-36 ml/min/1.73 m(2), respectively. Although GFR estimated by creatinine and cystatin C had a significant correlation, the Bland-Altman analysis showed greater differences between GFR estimated by the 2 methods, with a mean difference of 50 ml/min. Besides, >50% of the patients with a reduced cystatin C estimated GFR had a normal GFR when analyzed by the Schwartz formula.
CONCLUSIONS: Our data shows that cystatin C-based GFR is more sensitive than previous study had demonstrated. It is important to perform studies in specific populations to determine the variability in GFR measurements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298952     DOI: 10.1016/j.cca.2008.02.004

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.

Authors:  Antigoni Pavlaki; Nikoleta Printza; Evangelia Farmaki; Stella Stabouli; Anna Taparkou; Magdalini Sterpi; John Dotis; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2019-10-13       Impact factor: 3.714

Review 2.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

3.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

4.  Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus.

Authors:  Xiaopang Rao; Meiyan Wan; Caixia Qiu; Chongcai Jiang
Journal:  Exp Ther Med       Date:  2014-06-30       Impact factor: 2.447

5.  No Impact of the Analytical Method Used for Determining Cystatin C on Estimating Glomerular Filtration Rate in Children.

Authors:  Martin Alberer; Julia Hoefele; Marcus R Benz; Arend Bökenkamp; Lutz T Weber
Journal:  Front Pediatr       Date:  2017-04-11       Impact factor: 3.418

6.  High-Risk Indicators of Renal Involvement in Primary Sjogren's Syndrome: A Clinical Study of 1002 Cases.

Authors:  Jing Luo; Yu-Wei Huo; Jian-Wu Wang; Hui Guo
Journal:  J Immunol Res       Date:  2019-02-17       Impact factor: 4.818

7.  Association of neutrophil gelatinase associated lipocalin and cystatin-C with kidney function in children with nephrotic syndrome.

Authors:  Alaleh Gheissari; Zahra Rezaii; Alireza Merrikhi; Yahya Madihi; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2013-08

Review 8.  Cystatin C: a new renal marker and its potential use in small animal medicine.

Authors:  L Ghys; D Paepe; P Smets; H Lefebvre; J Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.